Study of Blood Samples From Newborns With Down Syndrome
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Sponsor: Children's Oncology Group
This observational or N/A phase trial investigates Myeloid Proliferations Associated With Down Syndrome and is currently completed. Children's Oncology Group leads this study, which shows 18 recorded versions since 2009 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2023 — Nov 2023 [monthly]
Active Not Recruiting
▶ Show 13 earlier versions
-
Apr 2022 — Apr 2023 [monthly]
Active Not Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Active Not Recruiting
-
Apr 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Active Not Recruiting
-
Sep 2018 — Nov 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
Status: Completed → Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Feb 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Oncology Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .